Literature DB >> 5148579

Human cyclofusional response.

R A Crone.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5148579     DOI: 10.1016/0042-6989(71)90018-6

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


× No keyword cloud information.
  9 in total

1.  Optically induced eye torsion. I. Fusion cyclovergence.

Authors:  R A Crone; Y Everhard-Hard
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-07-04

2.  A second neural mechanism of binocular depth discrimination.

Authors:  C Blakemore; A Fiorentini; L Maffei
Journal:  J Physiol       Date:  1972-11       Impact factor: 5.182

3.  Tolerance for aniseikonia. II. Determination based on the amplitude of cyclofusion.

Authors:  R A Crone; O M Leuridan
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1973-07-31

4.  Comments on cyclofusional eye movements.

Authors:  S Krekling
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1973-10-19

5.  The intraocular implant lens development and results with special reference to the Binkhorst lens.

Authors:  M E Nordlohne
Journal:  Doc Ophthalmol       Date:  1974-12-16       Impact factor: 2.379

6.  Cyclovergence: the motor response to cyclodisparity.

Authors:  K Hooten; E Myers; R Worrall; L Stark
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-03-05

7.  The dependence of cyclofusion on orientation.

Authors:  R P O'Shea; B Crassini
Journal:  Percept Psychophys       Date:  1982-08

8.  The superior oblique: a challenging extraocular muscle.

Authors:  A Neetens; M Janssens
Journal:  Doc Ophthalmol       Date:  1979-03-15       Impact factor: 2.379

9.  Comparison of torsional amplitudes between emmetropes and myopes using after-image slides.

Authors:  Antony Arokiadass Baskaran; Tanuja Britto; Sundaresan Rajkumar; Philip A Thomas; C A Nelson Jesudasan
Journal:  Indian J Ophthalmol       Date:  2019-05       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.